Tacrolimus
NDC 82009-165, Tacrolimus, capsule, from Quallent Pharmaceuticals Health LLC.
- Product NDC
- 82009-165
- Status
- Listed
- Labeler
- Quallent Pharmaceuticals Health LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090509
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82009-165 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TACROLIMUS5 mg/1
Pharmacologic classes
Calcineurin Inhibitor Immunosuppressant [EPC]; Calcineurin Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82009-165-01 | 82009016501 | 100 CAPSULE in 1 BOTTLE (82009-165-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/23b7b4d7-1431-e9f2-43ba-eabd169dc2ddNADAC price for package 82009016501
GET /v1/drugs/nadac/82009016501
Use it
Look up 82009-165 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82009-165 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82009-165. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.